Given the marked differences between both models and that Rac1 is attractive for therapeutically targeting invasion dynamics in glioma, we further established an orthotopic intracranial LN229 mouse model to evaluate 1A-116 efficacy. The gene discussed is RAC1; the disease is glioma.